Healthcare provider profile · identity verified

Robert Sullivan

Internal Medicine · ALTOONA, PA · NPI 1790971273

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	207	56
Atorvastatin Calcium	Atorvastatin Calcium	204	46
Gabapentin	Gabapentin	190	33
Amlodipine Besylate	Amlodipine Besylate	185	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	175	31
Pantoprazole Sodium	Pantoprazole Sodium	174	44
Alprazolam	Alprazolam	167	41
Levothyroxine Sodium	Levothyroxine Sodium	149	30
Tamsulosin Hcl	Tamsulosin Hcl	145	22
Lorazepam	Lorazepam	126	36
Losartan Potassium	Losartan Potassium	118	26
Metoprolol Succinate	Metoprolol Succinate	104	27
Omeprazole	Omeprazole	98	26
Furosemide	Furosemide	96	26
Simvastatin	Simvastatin	86	22
Clonazepam	Clonazepam	85	14
Zolpidem Tartrate	Zolpidem Tartrate	80	20
Metoprolol Tartrate	Metoprolol Tartrate	78	11
Hydrochlorothiazide	Hydrochlorothiazide	73	20
Azithromycin	Azithromycin	71	26
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	69	suppressed
Oxycodone Hcl	Oxycodone Hcl	66	13
Vancomycin Hcl	Vancomycin Hcl	65	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	12
Trazodone Hcl	Trazodone Hcl	63	suppressed
Eliquis	Apixaban	62	suppressed
Metformin Hcl	Metformin Hcl	58	16
Sertraline Hcl	Sertraline Hcl	57	17
Buspirone Hcl	Buspirone Hcl	56	11
Clopidogrel	Clopidogrel Bisulfate	55	13
Albuterol Sulfate Hfa	Albuterol Sulfate	49	17
Ethambutol Hcl	Ethambutol Hcl	48	suppressed
Rifampin	Rifampin	48	suppressed
Finasteride	Finasteride	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	46	16
Allopurinol	Allopurinol	45	suppressed
Synthroid	Levothyroxine Sodium	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	13
Tramadol Hcl	Tramadol Hcl	39	17
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Meloxicam	Meloxicam	38	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	38	suppressed
Cefadroxil	Cefadroxil	37	11
Triumeq	Abacavir/Dolutegravir/Lamivudi	37	suppressed
Cephalexin	Cephalexin	36	19
Dutasteride	Dutasteride	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	15
Glimepiride	Glimepiride	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Potassium Chloride	Potassium Chloride	33	12
Cefuroxime	Cefuroxime Axetil	32	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	21
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Atenolol	Atenolol	30	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	30	19
Ozempic	Semaglutide	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Efavirenz	Efavirenz	29	suppressed
Fluconazole	Fluconazole	29	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Prednisone	Prednisone	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Jantoven	Warfarin Sodium	25	suppressed
Lamivudine-Zidovudine	Lamivudine/Zidovudine	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Fentanyl	Fentanyl	22	suppressed
Ritonavir	Ritonavir	22	suppressed
Tivicay	Dolutegravir Sodium	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Daptomycin	Daptomycin	21	suppressed
Temazepam	Temazepam	21	suppressed
Amoxicillin	Amoxicillin	20	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Cefepime Hcl	Cefepime Hcl	17	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	17	suppressed
Famotidine	Famotidine	17	suppressed
Lamivudine	Lamivudine	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Nystatin	Nystatin	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Darunavir	Darunavir	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Methylprednisolone	Methylprednisolone	15	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Ertapenem	Ertapenem Sodium	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Zaleplon	Zaleplon	14	suppressed
Abacavir	Abacavir Sulfate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Digoxin	Digoxin	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error